1. C U R R I C U L U M V I T A E
GHADA METWALLY TAWFICK ELGOHARY, MD
PERSONAL
INFORMATION:
Nationality:
Birth year:
Place of Birth:
Marital Status:
Language spoken:
Egyptian
19 September 1972
Egypt
Married
Arabic,English
RELEVANT
QUALIFICATIONS:  Internist, qualified from Egypt (MBBCh, M.Sc. and M.D. Internal Medicine) Practiced
for more than 15 years as an internist with special interest in General Medicine and
Adult Hematology/Oncology
 Academic background with more than 15 years of working in the Department of
Internal Medicine (Hematology and Bone Marrow Transplantation Unit), Faculty of
Medicine, Ain Shams University (currently appointed as Assistant Professor)
 Proven skills of teaching in various setups including undergraduate,postgraduate,
nursing, teaching to the public as well
 Demonstrated interest and continuous contribution in clinical research with 5
international and 10 national publications in addition to posters and presentations in
medical conferences
 Practiced in governmental and private health sectors in different levels of health care
 Bone Marrow Transplant experience in one of the biggest hospitals In the Middle East,
King Faisal Specialist Hospital &Research Center, Riyadh, Saudi Arabia
PROFESSIONAL
EXPERIENCE
AND TRAINING:
July 2016 –present
May 2012 – Present
Aug 2011 - Present
May 2010 - Present
Aug 2006 – Aug 2011
Professor
Department of Internal Medicine and Hematology unit
Ain Shams University Hospitals, Cairo, Egypt
Assistant Professor in Internal Medicine/Adult Hematology
Al Faisal University, Riyadh, Saudi Arabia
Assistant Professor
Department of Internal Medicine and Hematology unit
Ain Shams University Hospitals, Cairo, Egypt
Assistant Consultant
Section of Adult Hematology, Oncology Centre
King Faisal Specialist Hospital and Research Centre
Riyadh, Saudi Arabia
Lecturer
Department of Internal Medicine and Hematology Unit
Faculty of Medicine, Ain Shams University Hospitals
Cairo, Egypt
BUSINESS ADDRESS:
Section ofAdult Hematology/HSCT
Oncology Centre (MBC-64)
King Faisal Specialist Hospital and Research Center
PO Box 3354, Riyadh 1211, Saudi Arabia
Mobile: +966 504 462 057
Email: gel-gohary99@kfshrc.edu.sa
ffice : 9: 966-1-442-3941
PERSONAL ADDRESS:
KFSH&RC ,RIYADH,KSA
E-mail: ghelgohary@yahoo.com

2. Curriculum Vitae
Ghada Elgohary , MD Page 2 of 11
Updated: 13 January 2015
May 2001 – May 2006
May 1998 – May 2001
Mar 1997 - Feb 1998
Assistant Lecturer
Department of Internal Medicine and Hematology Unit
Faculty of Medicine, Ain Shams University Hospitals
Cairo, Egypt
Resident
Department of Internal Medicine and Hematology Unit
Ain-Shams University Hospitals, Cairo, Egypt
House Officer
Ain Shams University Hospital
Cairo, Egypt
QUALIFICATIONS AND
CERTIFICATIONS:
Apr 2006
Nov 2000
Sep 1989 – Feb 1996
Dec 1986 – Jun 1989
Doctor’s Degree in Medicine
Master’s Degree In Medicine
M.B,B.CH (Bachelor of Medicine and Surgery)
Ain Shams University School of Medicine
Cairo, Egypt
High School diploma
Saint Clair College, Sciences and Biology
Cairo, Egypt
MEDICAL SCHOOL
AWARDS:
 Bachelor of Medicine and Surgery (M.B, B.CH) Excellent,
with Honor
 Master’s Degree in Medicine, Very Good
 Doctor’s Degree in Medicine
 Certificate of Honor of the Model Physician 2000 from
Cairo Medical Syndicate
MEMBERSHIPS: Member
Member
Member
Member
Member
Member
Member
Member
Member
Member
 Egyptian Society of Hematology (ESH)
 Egyptian Medical Syndicate
 Egyptian Hematology/Oncology Group(EHOG)
 Arab Society of Infectious Diseases and
Antimicrobials(ASIDA)
 International Society Of Hematology (ISH)
 American Society Of Hematology (ASH)
 Eastern Mediterranean Bone Marrow Transplantation
(EMBMT)
 Saudi scientific society of Blood &marrow
Transplantation(SSBMT)
 Saudi SCIENTIFIC Hematology society
 Saudi Oncology society (SOS)

3. Curriculum Vitae
Ghada Elgohary , MD Page 3 of 11
Updated: 13 January 2015
TEACHING EXPERIENCE:  Clinical rounds and Lectures for under and Postgraduate
medical students
 Teaching sessions for Undergraduates and House Officers
 Sharing in Postgraduate Teaching Programs.
 Sharing Under and Postgraduate exam preparations
ACADEMIC ACTIVITIES:  Sharing in the preparation of weekly Scientific Hematology
Meeting.
 Sharing in the preparation of Rota of Lecturers, Assistant
Lecturers and Residents in the A&E.
 Sharing in the preparation of monthly Morbidity &
Mortality meeting in the Department of Internal Medicine
and Hematology unit in Ain Shams University
 Sharing in the preparation of the International Annual Ain
Shams University Medical Congress
 May 2011, Passing the International English Language
Testing System(IELTS)
CLINICAL EXPERIENCE:  Daily ward round (40 beds)
 Weekly Internal Medicine OPC
 Weekly Hematology OPC
 Sharing in Bone Marrow transplantation educational
programs
 Moderator of bone marrow transplantation unit in
Demerdash hospital for four month during 2007
 Dec 2008- Apr 2010, Moderatorof the Internal Medicine
Department in Zyton Specialist Hospital
 Jan 2010– Apr 2010, Moderator of Hematology unit
Internal Medicine Department
Ain Shams University Hospital
VOLUNTEER
EXPERIENCE:
Mar – Oct 1997  Family Doctor Ministry of Health of Egypt
I had volunteered as a family doctorin one of the Egyptian
ministry of health medical centers.The center was located
in downtown Cairo and was concerned with an area serving
thousands ofpeople and my main duty was concerned
mainly with family counseling,antenatal care, and
compulsory vaccination, dealing with medical cases and
selecting those cases in need of referral to specialized
centers

4. Curriculum Vitae
Ghada Elgohary , MD Page 4 of 11
Updated: 13 January 2015
OTHER INFORMATION: The University Training Program at Ain Shams University
is composed of 1 year during which I rotated for 2 months in each of the following
Departments: - Internal Medicine -Pediatric - Obstetrics and Gynecology - General Surgery
- Neurosurgery - Anesthesiology and Emergency Medicine. Ain Shams University is
ranked first in Egypt. Ain Shams University Hospitals were built in 1935 and since then,
they have been expanding enormously in different specialties. ASU has two main
hospitals:El-Demerdash and Specialist Hospitals.
The combined General Hospitals and Specialist Hospital of the University represent the
largest Hospital Complex in the middle east and Africa (>4000 beds). Owing to the unique
location of Ain Shams University Hospitals in central Cairo, it serves over18 million
Cairenian citizens excluding those referred from otherlocations. The training program
entails direct responsibility of patient care under supervision of senior residents and
professors.Also,it includes dealing with common cases,critically ill patients,ICU
rotation, CCU and caring for accidents and emergencies.
Clinical Hematology is a large unit with its own Hemato-pathology laboratory with an
access to do Immunophenotyping, cytogenetics and molecular. It is 42-bed units with an
affiliated 7-bed transplant unit for allo-transplantation. We see a lot of different varieties of
hematology including, AML, ALL, NHL, HCL, Myeloma and rare conditions like PNH
and SAA.
The Bone Marrow Transplant Program (BMT) at King Faisal Specialist Hospital &
Research Centre
is an internationally renowned leader(JCIA accredited) in the blood and marrow
transplantation for more than 23 years including malignant diseases and Lymphomas,
nonmalignant diseases such as Aplastic Anemia and a variety of inherited diseases.To
date, over 2,900 bone marrow transplants have been performed at the Oncology Centre,
which is fully accredited by the National Marrow Donor Program as an unrelated donor
transplant center.
At the opening of the King Faisal Specialist Hospital and Research Centre in 1975, cancer
treatment facilities consisted ofa 600 sq. meter area housing,three examination rooms, a
reception and waiting area, a mould room, a simulator and three radiation treatment
machines. The Hospital now enjoys the largest cancer facilities in the Gulf region. An
independent,four-story building of over 7,500 sq. meters accommodates Radiation
Oncology treatment and outpatient areas on the ground floor and outpatient examination
and treatment areas for other Sections on the 2nd and the 3rd floors. There is an
intravenous admixture pharmacy on the 2nd floor and a dispensing outpatient pharmacy on
the 3rd floor. The 56 station chemotherapy treatment areas are divided between the two
floors, with 14 reclining chairs for bolus injections and 14 prolonged infusion beds on each
floor. The 4th floor houses physician offices, the Oncology Data Unit, the Hospital Tumor
Registry, the National Cancer Registry of the Kingdom of Saudi Arabia, and the (Arabian)
Gulf Center for Cancer Registration. 46,400 Cancer cases have been registered in the
Hospital Tumor Registry to date.
The Research Unit consists ofdynamic staff of clinical research coordinators, tumor
registrars, progenitor stem cell transplant registry staff and statistician that lends support
for sponsored clinical research as well as helps maintain one of the world’s largest cancer
registries.

5. Curriculum Vitae
Ghada Elgohary , MD Page 5 of 11
Updated: 13 January 2015
PRESENTATIONS:
International Presentations 2007
March 2008
June 2008
January 2009
October 2009
 American Society For Clinical Pathology (ASCP) Meeting
YM EL-Gohary, MJ Robinson,RJ Poppiti, G Metwally, RS
Saad, PG Azar.
Correlation of lymphatic and blood vasculardensities with
morphologic subtypes ofintraductalcarcinoma of the breast
Am J ClinPathol 2007; 128(4):685-6 Paper in Press for the
Breast Journal
 Ain Annual Shams International Medical Congress
Bone Marrow transplantation in Ain Shams University:
Evidence from Experience GRAFT FAILURE.
 13th Congress Of The European Hematology Association,
Copenhagen,Denmark
Study Of Ascorbate (Vitamin C) Status in Chronic Myeloid
leukemia patients.
 30th Annual Conference Of the Egyptian Society Of
Hematology
Imatinib Resistance: Molecular Pathogenesis
 XXth Congress of International Society of Hematology
(ISH) European and African Division
JAK2 V617F mutation in Budd Chiari Syndrome: Egyptian
Experience.
Poster Presentations July 2010
April 2011
April 2011
December 2011
April 2012
April 2012
 21st International Thrombosis Congress
The Platelet Function Analyzer - Collagen epinephrine
systemreveals the importance of hemostatic risk
management in Myeloproliferative neoplasia patients
particularly CML with thrombocytosis.
 37th Annual Meeting of the European Group for Blood and
Marrow Transplantation (EBMT) Outcome of autologous
hematopoietic stemcell transplantation in adults with acute
myeloid leukemia using three different Conditioning
regimens.
 37th Annual Meeting of The European Group for Blood and
Marrow Transplantation (EBMT) Favorable outcome of
single locus related mismatch HSCT for Class I antigen in
patients of Eastern Mediterranean background
 The 53rd ASH AnnualMeeting: Discrepancies in Serum
Free Light Chain Assays and Immunofixation for Response
Evaluation and Prognostication in Plasma Cell Proliferative
Disorders
 38th Annual Meeting of the European Group for Blood and
Marrow Transplantation (EBMT) Impact of surface CD20
expression on prognosis of adolescents and young adults
with pre B acute lymphoblastic leukemia treated with a
unified risk –stratified protocol.
 38th Annual Meeting of the European Group for Blood and
Marrow Transplantation (EBMT) Allogeneic hematopoietic
stem cell transplantation from mostly sibling donors for

6. Curriculum Vitae
Ghada Elgohary , MD Page 6 of 11
Updated: 13 January 2015
13-16 June 2013
11-14 June 2015
2-7 April 2016
adolescent and adult patients with high risk acute
lymphoblastic leukemia: 20years experience.
 18th Congress of the European Hematology Association,
Stockholm, Sweden
Acute myeloid leukemia – Biology
EHA18ABSSUB-4428
Study of cd123 (interleukin-3 receptor alpha chain) and nf-
κb (nuclear factor kappa b) in adult acute myeloid leukemia
patient.
 Evaluation of bone mineral density in young adult acute
lymphoblastic leukemia (all) patients:a single center
egyptian. EHA-3375
 Hematopoietic Cell Transplantation including Autologous
Transplantation leads to superior Free Disease Survival in
young Adults with t(8;21) AML. EBMT16-PH-2169
Oral Presentation December 2011  The 53rd ASH AnnualMeeting: The t (9;11) confers Good
Prognosis in AML Patients Treated with Stem Cell
Transplantation As Compared to Non –t (9;11)and Other
Adverse –Risk Abnormalities
Letter of Editor in HematolOncol Stem Cell Ther 5 (3)
Third Quarter 2012
OTHER
AWARDS/ATTENDANCE
ACCOMPLISHMENTS:
 Thesis entitled “Clinical Relevance Of Telomerase Activity In Egyptian Adult Acute
Lymphoblastic Leukemia: Correlation with Apoptosis and Survival” ”Postured in the
27th Annual Congress of the Egyptian Society Of Hematology in collaboration with
the Egyptian Association OF Transfusion Medicine” 14-15th December 2005 –
Pyramiza Hotel, Giza.
 Thesis entitled ‘Serum Thrombopoietic in Thrombocytosis Due To Various
Aetiologies” published in the Ain Shams University Hematology Journal.
 Attending the ASCO-PANARAB Conference ON Malignant Lymphoma And The
Evolving Role Of Stem Cell Transplantation Nov.,1999
 Attending the Egyptian Society of Applied Endocrinology January, 2000.
 Attending 3rd Diabetic Foot Workshop April 2003 in King Faisal Hospital, Taif.
 Attending the Second Intensive Course of Endocrinology, Diabetes and Metabolism
June 2004.
 Attending the first PAN_ARAB Critical Care Medicine Congress May 2005, Al Hada
Armed Forces Hospital, Taif, Saudi Arabia
 Attending The Egyptian Society Of Pediatric Hematology Oncology March, 2006
 Attending the 12th Annual Scientific Conference of the Egyptian Group of Diabetes
October 2007
 Attending the 9th Annual Congress of Egyptian Society of Pancreatic Islet
Transplantation Research for Diabetic Patients November 2007.
 Attending the 9th Pan Arab Cancer Congress May 2009
 Attending the XXth Congress of International Society of Hematology (ISH) European
and African Division, October, 2009 with two posterpresentations and oral
presentation.
 Attending the 52nd ASH Annual meeting And Exposition December, 2010.

7. Curriculum Vitae
Ghada Elgohary , MD Page 7 of 11
Updated: 13 January 2015
 Attending the 2nd AnnualSymposium on Hematological Malignancies, Riyadh,
KFSH&RC
 Attending the 11th international conference on Malignant Lymphoma, Riyadh, KSAU-
HS
 Attending the EMBMT Scientific Symposium, Dubai , November, 2011
 Attending the 53rd ASH Annualmeeting And Exposition, December, 2011
 Attending the 38th EBMT Annualmeeting, April 2012
 Attending Statistical course of the EBMT,Geneva,April 2012
 Attending the Biostatistics Course in oncology centre ,KFSH&RC,Riyadh ,July,2012
 Attending the 54th ASH Annual meeting And Exposition, December, 2012
 Attending the 39th Annual meeting EBMT , April, 2013
 Attending the EMBMT Scientific Symposium, Muscat,November 2013
 Attending the 55th ASH Annual meeting And Exposition, December 2013
 Attending the 18th Congress of the European Hematology Association,June 2014
 Attending the 56th ASH Annual meeting And Exposition, December 2014
 Attending the 19th Congress of the European Hematology Association,June 2015
 Attending the clinical Research Development Workshop,Riyadh,December,2015
 Attending Pan Arab meeting, Cairo,February 2016
The International Experiences:
 Attending the first PAN_ARAB Critical Care Medicine Congress May 2005, Al Hada
Armed Forces Hospital, Taif, Saudi Arabia
 Participation in International Postgraduate Observership program in the course of
Hematology / Oncology in Mount Sinai Medical center, Miami Beach, Florida, United
States of America from January 2/2007 through January 26/2007
 Participation in International postgraduate Observership program, in the course of
Clinical pathology in Mount Sinai Medical Center, Miami Beach, Florida United
States of America, 05 February – 02 March 2007
 Attending the Euro-Arab School of Oncology (EASO) Masterclass, September 2007
 Attending the International Congress on Bone Marrow & Stem Cell Transplantation,
King Faisal Specialist Hospital & Research Center; November 2007
 Attending the Protocol ICL670ATR01 Investigators, Meeting, Bali, Indonesia; May
24, 2008
 Attending the Euro-Arab School of Oncology (EASO) Masterclass on Lymphoma,
January, 2009
 Participation in international postgraduate Observership programin the course of Bone
Marrow Transplantation in Virginia Commonwealth University, Medical Center,
February/2009
 Passing IELTS Exam in May 2011
 Participation in King Faisal Specialist Hospital Handbook guidelines for management
of hematologic malignancies (Fourth Edition)
 Participation in international postgraduate Observership programin the course of Bone
Marrow Transplantation in EASO Hematological center ,Milano,2016
REFERENCES Mahmoud Aljurf, MD
Director, Adult HSCT Program
Deputy Director, Oncology Centre
Scientific Director, EMBMT
King Faisal Specialist Hospitaland Research Centre
PO Box 3354, Riyadh 11211, Saudi Arabia

8. Curriculum Vitae
Ghada Elgohary , MD Page 8 of 11
Updated: 13 January 2015
Tel: +966 11 442 4586
Email: maljurf@kfshrc.edu.sa
Fahad Almohareb, MD
Head, Section of Adult Hematology/HSCT
Oncology Centre (MBC-64)
King Faisal Specialist Hospitaland Research Centre
PO Box 3354, Riyadh 11211, Saudi Arabia
Tel: +966 11 442 3933
Email: fmohareb@kfshrc.edu.sa
PUBLICATIONS
1. Pre-Conditioning Steroids and Hydroxyurea Followed By Reduced Toxicity Conditioning (RTC) with ATG-
Bu-FLU Is Safe and Effective in Allo-Sib-HSCT in Adolescents and Adults with Sickle Cell Anemia (SCA)
Said Yousuf Mohamed, MD.,Hazzaa Alzahrani.,Khaled T. Ibrahim.,Ghada Elgohary.,Ahmed Y. Gamal.,Amr
Hanbali.,Marwan Shaheen.,Walid K. Rasheed.,Wahiba Chebbo.,Osama Ali.,Rehab Albloushi.,Ahmad
Alhuraiji.,Naeem Chaudri.,Syed O. Ahmed,TussneemEl-Hassan.,Mahmoud Deeb Aljurf,Fahad Al-Mohareb
Biol Blood Marrow Transplant 21 (2015) S30eS53
2. PROGNOSTIC IMPACT OF FAT1 CADHERIN EXPRESSION IN ADULT ACUTE LYMPHOBLASTIC
LEUKEMIA Mahira I Elmougy and Ghada M. ElGohary
Int. J. of Adv. Res. Year 2015, 3 (10). 1489-1496] (ISSN 2320-5407).
3. Utility of Galactomanann monitoring in predicting Response to Empiric Antifungal therapy in Neutropenic
patients following intensive chemotherapy Hanan Hamed Abd Elhamid , Maryse Soliman Ayoub , Walaa Ali
Elsalakawy , Ahmad A. Ali , Ghada Metwally El Gohary - Int. J. of Adv.Res. 3 (9). 1391-1398
4. EVALUATION OF BONE MINERAL DENSITY IN YOUNG ADULT ACUTE LYMPHOBLASTIC
LEUKEMIA (ALL) PATIENTS: A single center Egyptian experience Inas Ahmed Asfour, Nevine Nabil

9. Curriculum Vitae
Ghada Elgohary , MD Page 9 of 11
Updated: 13 January 2015
Moustafa , Haitham Mohammed Abdelbary , Hala Nabil Dief , Mahmoud Ahmed Refaee , Mohammad Fahmy
Tolba , Ghada Metwally Elgohary
Int. J. of Adv. Res. 3 (9). 1359-1362
5. Value of CD11a and CD18 in flow cytometric immunophenotypic diagnosis of acute promyelocytic leukemia..
Azza M S El Danasoury,Abeer A Saad El Dein, Mervat A Al-Feky, Seham M Ezzat, Mohamed T Sallam, Gihan
M Kamal, Ghada Gohary, Rania I El-Meehy
Journal of Applied Hematology, Year 2015, Volume 6, Issue 1 [p. 19-26]
6. Immunoglobulin heavy-chain gene rearrangement in B-cell non-Hodgkin lymphoma using the fluorescence in-
situ hybridization technique.
Mohamed A. M. Mekawy, Manal M Ismail, Mahira I El Mogy, Ahmed M. M. Mostafa,Saad S Eissa, Samy A
Abu Sikkien, Ghada M ElGohary
The Egyptian Journal of Haematology, Year 2015, Volume 40, Issue 2 [p. 90-98]
7. Study of CD123 (interleukin-3 receptor alpha Chain) and nuclear factor kappa B in adult acute myeloid
leukemia patients.
Inas Asfour,Soha Yoyssef, Maryse Ayoub,Nevine Moustafa,Hani Ayash,TussneemElhassan, Ghada M
ElGohary
Journal of Applied Hematology, Year 2014, Volume 5, Issue 4 [p. 151-155]
8. Clinical and laboratory presentations ofJanus Kinase II-positive patients in Saudi population
H Malhan, H Alzahrani, Ghada M Elgohary, T Owaidah, M Aslam, Said Yousuf Mohamed
Journal of Applied Hematology, Year 2014, Volume 5, Issue 4 [p. 133-140]
9. Eight-hour versus 24-h whole-blood hold before preparation of platelet concentrates by the platelet-rich plasma
method
Azza S El-Danasoury, Mahira I El-Mogy, Amal Farouk, Ghada S Neseem, Ghada M El-Gohary
The Egyptian Journal of Haematology, Year 2014, Volume 39, Issue 4 [p. 195-201]
10. Methotrexate for the Treatment of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell
Transplantation. Nassar A, Elgohary G, Elhassan T, Nurgat Z, Mohamed SY, Aljurf M.
J Transplant.2014; 2014:980301. doi: 10.1155/2014/980301. Review
11. Measurement of the serum B-cell-activating factor of the tumor necrosis factor family (BAFF) in patients with
idiopathic thrombocytopenic purpura and its correlation with immunosuppressive therapy
Abd Elrahman A. Soliman, Maryse S. Ayoub,Mervat A. Al-Feky, Ghada M. Tawfick, Gihan M. Kamal,
Haitham M. Abd El Bary The Egyptian Journal of Haematology, Year 2012, Volume 37, Issue 2 [p. 67-72]
12. Allogeneic hematopoietic stemcell transplantation in adolescent and adult patients with high-risk T cell acute
lymphoblastic leukemia.
Bakr M, Rasheed W, Mohamed SY, Al-Mohareb F, Chaudhri N, Al-Sharif F, Al-Zahrani H, Al-Dawsari G,
Saleh AJ, Nassar A, Ahmed S, Elghazaly A, Ahmed SO, Ibrahim K, Chebbo W, El Gohary GM, Al Mahayni
MH, Hussain F, Nurgat Z, Elhassan TA, Walter CU, Aljurf M.
Biol Blood Marrow Transplant. 2012 Dec;18(12):1897-904.
13. The t(9;11) confers good prognosis in AML patients treated with stemcell transplantation as compared to non -
t(9;11) and other adverse-risk abnormalities.
Walter CU, Mohareb FA, Chaudhri N, Alsharif F, Zahrani HA, Mohamed S, Rasheed W, Saleh AJ, Chebbo W,
El Gohary G, Aljurf M, Albitar M. Hematol Oncol Stem Cell Ther. 2012;5(3):169-70

10. Curriculum Vitae
Ghada Elgohary , MD Page 10 of 11
Updated: 13 January 2015
14. Myeloid sarcoma of the vulva post-bone marrow transplant presenting as isolated extramedullary relapse in a
patient with acute myeloid leukemia.
Nazer A, Al-Badawi I, Chebbo W, Chaudhri N, El-Gohary G.
Hematol Oncol Stem Cell Ther. 2012;5(2):118-21.
15. Donor-derived extramedullary acute promyelocytic leukemia post kidney transplant.
Alhuraiji A, Chebbo W, El-Gohary G, Chaudhri N, Almohareb F, Ibrahim K, Bakshi N, Mohammed S,
Abalkhail H, Osman SA.
Ann Hematol. 2014 Sep 9.
16. Leukemia during pregnancy:long termfollow up of 32 cases from a single institution.
Saleh AJ, Alhejazi A, Ahmed SO, Al Mohareb F, AlSharif F, AlZahrani H, Mohamed SY, Rasheed W,
AlDawsari G, Ibrahim K, Ahmed S, Chebbo W, ElGohary G, Almahayni M, Chaudhri N, Aljurf M.
Hematol Oncol Stem Cell Ther. 2014 Jun;7(2):63-8.
17. Biofilm forming bacteria isolated from urinary tract infection, relation to catheterization and susceptibility to
antibiotics
Nermeen Mahmoud Ahmed Abdallah1, Shereen Bendary Elsayed, Manal Mohamed Yassin Mostafa1
and Ghada Metwally El-gohary
International Journal for Biotechnology and Molecular Biology Research Vol.2(10),pp. 172 -178,October 2011.
18. Stem cell transplantation in hematological disorders.A developing country experience-impact of cost
considerations. El-Zimaity MM, Hassan EA, Abd El-Wahab SE, Abd El-Ghaffar AA, Mahmoud NA, Elafifi
AM, Moussa MM, El-Gohary GM, Hagras MM, Mowafy NM.
Saudi Med J. 2008 Oct;29(10):1484-9.
19. Pro-inflammatory cytokines and depression in patients with acute leukemia.
El-Gohary GM, Azzam HM, Ahmed OI, El-Shokry MH.
Egypt J Immunol. 2008;15(1):13-24.
20. Correlation of telomerase activity to apoptosis and survivalin adult acute lymphoblastic leukemia: an Egyptian
single-center study.
IA, Fayek MH, El-Kourashy SA, Youssef SR, El-Gohary GM, Mohamed OF.
Ann Hematol. 2008 Mar; 87(3):213-21. doi: 10.1007/s00277-007-0395-2
21. Right heart thrombus-in-transit with pulmonary embolism in a patient with primary hypercoagulable state.
II, Samir S, Abbas O, El-Gohary GM, Nammas W.
Cardiol J. 2010;17(4):408-11
22. List of publication in Riyadh news paper with the following links:
‫الدعم‬‫السرطان‬ ‫لمريض‬ ‫وأهميته‬ ‫النفسي‬
‫د‬.‫غـادة‬‫متـولي‬‫الجوهـري‬*
: ‫التاريخ‬2102/01/10
http://www.alriyadh.com/773575
‫العظام‬ ‫نخاع‬

11. Curriculum Vitae
Ghada Elgohary , MD Page 11 of 11
Updated: 13 January 2015
‫د‬.‫غـادة‬‫متـولي‬‫الجوهـري‬*
: ‫التاريخ‬2102/10/10
http://www.alriyadh.com/724608
‫المرتفعة‬ ‫الوفاة‬ ‫مرض‬
‫د‬.‫غادة‬‫متولي‬‫الجوهري‬*
: ‫التاريخ‬2102/10/02
http://www.alriyadh.com/700285
‫العميقة‬ ‫األوردة‬ ‫وجلطات‬ ‫الحمل‬
‫د‬.‫غادة‬‫متولي‬‫الجوهري‬*
: ‫التاريخ‬2100/10/20
http://www.alriyadh.com/652523